<DOC>
	<DOCNO>NCT02519465</DOCNO>
	<brief_summary>The aerosol associate noninvasive ventilation ( NIV ) high flow therapy nasal interface employ attempt relieve respiratory distress optimize deposition drug inhalation . Some study report effect NIV association fog healthy subject , asthmatic COPD 7.8 , study evaluate association high flow nasal mist interface therapy scarce find vitro animal model . The objective study evaluate deposition aerosol scintigraphy use high flow nasal interface system vibrate mesh nebulizer use healthy adult .</brief_summary>
	<brief_title>Evaluation Lung Deposition Aerosol Via HFNC Healthy Adults</brief_title>
	<detailed_description />
	<criteria>The study include healthy individual sex , 18 65 year , without history lung disease force vital capacity ( FVC ) force expiratory volume first second ( FEV1 ) high equal 80 % predicted value , ability verbal command understand willing provide sign consent participate study . Participants exclude unable understand follow procedure pregnant unable tolerate nebulization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>nasal cannula</keyword>
	<keyword>Inhalation Devices</keyword>
</DOC>